ID

43042

Descripción

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0) see http://clinicaltrials.gov/ct2/show/study/NCT00626548

Link

http://clinicaltrials.gov/ct2/show/study/NCT00626548

Palabras clave

  1. 22/11/11 22/11/11 -
  2. 22/11/11 22/11/11 -
  3. 27/3/14 27/3/14 - Martin Dugas
  4. 13/4/14 13/4/14 - Julian Varghese
  5. 17/9/21 17/9/21 -
Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility DRKS00003883 NCT00626548 Prostate Cancer

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Inclusion criteria
Descripción

Inclusion criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI-1
C0001779
Male
Descripción

Gender Male

Tipo de datos

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
Descripción

Prostate Cancer

Tipo de datos

boolean

Alias
UMLS CUI-1
C0600139
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Descripción

PSA

Tipo de datos

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Descripción

Castration

Tipo de datos

boolean

Alias
UMLS CUI-1
C0007347
Exclusion criteria
Descripción

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Currently using opiate based pain killers for cancer related pain
Descripción

Opiate

Tipo de datos

boolean

Alias
UMLS CUI-1
C0376196
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Descripción

Previous chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI-1
C1514457
Suffering from heart failure or had a myocardial infarction within last 6 months
Descripción

Heart disease

Tipo de datos

boolean

Alias
UMLS CUI-1
C0018799
A history of epilepsy or seizures
Descripción

Epilepsy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0014544

Similar models

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Gender Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
boolean
C0600139 (UMLS CUI-1)
PSA
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Opiate
Item
Currently using opiate based pain killers for cancer related pain
boolean
C0376196 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C1514457 (UMLS CUI-1)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018799 (UMLS CUI-1)
Epilepsy
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial